As the Government around the world race to combat the fast-spreading Delta variant, President Biden is facing growing calls to use his legal authority to force pharmaceutical giants to share their vaccine recipes. It is with a proposed patent waiver for coronavirus vaccines still mired in fruitless talks at the World Trade Organization.
The patent for key spike-protein technology created by the National Institutes of Health is presently held by the US Government. At least five companies, including Moderna, Pfizer, and Johnson & Johnson, have used that technique to assist trigger an immune response against the coronavirus in the development of vaccines.
Maybarduk is encouraged by recent comments from Gayle Smith, the chief of the US State Department’s global Covid-19 response. Smith asked US vaccine makers to assist build low-cost production hubs overseas and share their technological expertise in an interview with the Financial Times earlier this week. Maybarduk, on the other hand, made it apparent that, given the Biden administration’s legal capacity to compel their involvement.